日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Hepatogenic diabetes: three cases report and literature review]

【肝源性糖尿病:三例病例报告及文献复习】

Amosova, M V; Poluboyarinova, I V; Salnikova, P V; Zherebchikova, K Y; Fadeev, V V

A case report of delirium tremens in a patient with myasthenia gravis

重症肌无力患者出现震颤性谵妄的病例报告

Karamullina, R A; Ismailova, S M; Pesheva, E D; Poluboyarinova, I V; Poluektov, M G; Fadeev, V V; Palinić, V; Krešić Ćorić, M; Zovko, N

[The history of the pharmacotherapy of obesity]

【肥胖症药物治疗史】

Berkovskaya, M A; Gurova, O Yu; Surkova, E V; Fadeev, V V

[Adaptation of the 12-item medication adherence scale ( the Questionnaire for assessment of adherence to Medication) on a Russian-speaking sample of patients with type 1 and type 2 diabetes mellitus]

[针对俄语人群中 1 型和 2 型糖尿病患者,对 12 项药物依从性量表(药物依从性评估问卷)进行改编]

Epishin, V E; Kalashnikova, M F; Likhodey, N V; Bondareva, I B; Kaurova, A M; Tulupova, M V; Nikolaev, N A; Fadeev, V V

[Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis]

[2型胺碘酮诱发的甲状腺毒症:糖皮质激素治疗的疗效,一项回顾性分析]

Ermolaeva, A S; Fadeev, V V

[Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development]

[2型胺碘酮诱发甲状腺毒症:患病率、发病时间和预测因素]

Ermolaeva, A S; Fadeev, V V

[Survival predictors in patients with ectopic acth syndrome]

[异位ACTH综合征患者的生存预测因素]

Golounina, O O; Belaya, Zh/ E; Rozhinskaya, L Ya; Pikunov, M Yu; Markovich, A A; Dzeranova, L K; Marova, E I; Kuznetsov, N S; Fadeev, V V; Melnichenko, G A; Dedov, I I

[Time-restricted eating as a novel strategy for treatment of obesity and it's comorbid conditions]

[限时进食作为治疗肥胖及其并发症的一种新策略]

Berkovskaya, M A; Gurova, O Y; Khaykina, I A; Fadeev, V V

Melanin distribution from the dermal-epidermal junction to the stratum corneum: non-invasive in vivo assessment by fluorescence and Raman microspectroscopy.

从真皮-表皮交界处到角质层的黑色素分布:通过荧光和拉曼显微光谱进行非侵入性体内评估

Yakimov B P, Shirshin E A, Schleusener J, Allenova A S, Fadeev V V, Darvin M E